Recruiting soon

The Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
What is being collected

Data Collection

Collected at a single point in time - Cross-sectional
Who is being recruted

Autoimmune Diseases+16

+ Brain Damage, Chronic

+ Brain Diseases

Over 2 Years
+10 Eligibility Criteria
See all eligibility criteria
How is the trial designed

Case-Control

Comparing exposures between individuals with and without disease in order to identify potential risk factors.
Observational
Study Start: August 2024
See protocol details

Summary

Principal SponsorExoneural Network AB
Study ContactMimi Westerlund, PhdMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Study start date: August 1, 2024

Actual date on which the first participant was enrolled.

The registry is designed to demonstrate the impact of Exopulse Mollii Suit on improvement and relaxation of muscles, muscle activation, local blood circulation and chronic pain relief. The subjects will serve as their own control and the data will be collected before, during and after the treatment period. As the electrical stimulation from the suit usually is above the level of sensation, the study participant cannot be blinded to the treatment. To prevent bias, multiple investigators will be collecting the data and only standardized and validated methods will be used. All investigators will be trained on the measurements prior to the registry start. Additionally, all investigators are trained and certified in the Exopulse method, and the generic stimulation settings are selected according to a standardized matrix based on the subjects' age and level of impairment. Re-assessments during scheduled visits are part of normal routine and use. The decision whether the subjects will be enrolled in the registry is separated from the subject's decision to use the device.

Official TitleThe Exopulse Mollii Suit Study - a Database for Routine Follow-up of Clinical Outcomes
NCT05901259
Principal SponsorExoneural Network AB
Study ContactMimi Westerlund, PhdMore contacts
Last updated: January 28, 2026
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

200 patients to be enrolled

Total number of participants that the clinical trial aims to recruit.

Case-Control

These studies compare people who have a disease (cases) with those who don't (controls). The goal is to look back at previous exposures or risk factors to identify what might have contributed to the disease.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 2 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Autoimmune DiseasesBrain Damage, ChronicBrain DiseasesCardiovascular DiseasesCentral Nervous System DiseasesCerebral PalsyCerebrovascular DisordersDemyelinating DiseasesImmune System DiseasesMultiple SclerosisNervous System DiseasesSpinal Cord DiseasesSpinal Cord InjuriesVascular DiseasesWounds and InjuriesTrauma, Nervous SystemAutoimmune Diseases of the Nervous SystemDemyelinating Autoimmune Diseases, CNSStroke

Criteria

5 inclusion criteria required to participate
Diagnosed with CP, MS, stroke, spinal cord injury or other neurologic disorder that may cause such type of symptoms.

Diagnosed >6 months prior to inclusion in case of MS, stroke, or SCI

Give written informed consent

Cognitively able to understand and follow verbal and/or written instructions

Show More Criteria

5 exclusion criteria prevent from participating
Any of the contraindications listed in the instructions for use of the Exopulse Mollii Suit

Being introduced to any new medication affecting the neuromuscular activity during the study period

Using botulinum toxin <3 month before or during the study period

Subjects <100 cm and <13 kg

Show More Criteria

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Study Objectives

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 1 location

Suspended

Exoneural Network Ab

Bergshamra, SwedenOpen Exoneural Network Ab in Google Maps
Recruiting soonOne Study Center